Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06881108 · ClinicalTrials.gov registry record
Addressing Financial Hardship in Adolescent and Young Adult Cancer Survivors
A clinical trial of Malignant Solid Neoplasm and Hematopoietic Neoplasm, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT06881108 is a study of Malignant Solid Neoplasm and Hematopoietic Neoplasm that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 16 participants, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06881108, a study of Malignant Solid Neoplasm and Hematopoietic Neoplasm, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to develop, test, and revise an intervention designed to address financial hardship (FinFit) among adolescent and young adult (AYA) cancer survivors.
Conditions Studied
Interventions
- OTHER CHAT Core Functions
- OTHER LIFT Core Functions
- OTHER Member-Checking Process
Study Locations (1)
North Carolina
- Wake Forest Baptist Comprehensive Cancer - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-11-04 |
| Est. Completion | 2025-09-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06881108
The ClinicalTrials.gov registry entry for NCT06881108 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (99% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which CHAT Core Functions is the first listed.
NCT06881108 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06881108 about?
NCT06881108 is a clinical study titled "Addressing Financial Hardship in Adolescent and Young Adult Cancer Survivors". This study seeks to develop, test, and revise an intervention designed to address financial hardship (FinFit) among adolescent and young adult (AYA) cancer survivors.
What is the current status of trial NCT06881108?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2024-11-04. Estimated completion is 2025-09-05.
What conditions does trial NCT06881108 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic Neoplasm, Lymphatic System Neoplasm.
What interventions are being tested in trial NCT06881108?
The interventions under investigation include: CHAT Core Functions (OTHER), LIFT Core Functions (OTHER), Member-Checking Process (OTHER).
Who is sponsoring clinical trial NCT06881108?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06881108 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
RECRUITING
-
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Voices: Messages of Wisdom and Hope in the Face of Illness
RECRUITING
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.